Sharjah To See 3 New Medicine Factories Worth Dh308.7 Million By 2026

The factories will specialise in producing respiratory products, eye drops, antibiotic capsules, stomach medications, and first aid materials. construction is underway, with completion expected between mid and late 2026.

These facilities will be part of an existing pharmaceutical plant in Sharjah.

Dr Munir Rayyan, chairman of the ICPM organising committee, highlighted the significance of these agreements in strengthening the pharmaceutical partnership between global companies and UAE-based factories.

The new factories signal the country's growing role in pharmaceutical innovation and its ability to compete globally in the health sector, he said.

With a $44-million investment, the first factory will produce eye drops and respiratory products. It will be completed by late 2026.

The second, a $35-million investment in a 10,000sqft space, will produce antibiotic capsules and stomach medications. It will have a production capacity of 600 million capsules annually, with operations starting in 2026.

The third factory, worth $5 million, will focus on first aid products, with construction set to begin later this year and completion expected early next year.